Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The mechanism of action for AOD 9604 involves stimulating fat breakdown and fat oxidation in adipose tissue, supporting research into its potential as a treatment for obesity and metabolic disorders
Evidence suggests carnitine supplementation supports efficient glucose metabolism
Further research is required to fully elucidate the KEAP1-dependent and -independent mechanisms of GSH-dependent regulation of NRF2
Subcutaneous vs Intramuscular Injection There are two injection routes used in practice: Subcutaneous (SubQ) the standard approach Reconstitute BPC-157 in bacteriostatic water as directed by your provider Inject under the skin in the abdomen, away from scar tissue Rotate injection sites to prevent localised irritation BPC-157 is water-stable and does not require acetate buffers practical for daily use Intramuscular (IM) for localised muscle injury Used when targeting a specific muscle group directly Less common in research protocols
If you're eating at maintenance or above, the injections have no mobilized fat to process
US$ 27.02
US$ 29.88
US$ 27.75
